PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 3, Pages -
Publisher
Springer Nature
Online
2018-03-07
DOI
10.1038/s41419-018-0401-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
- (2017) Amit Gupta et al. MOLECULAR CELL
- Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution
- (2017) Wei Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Childhood osteosarcoma: Incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2013
- (2017) F. Moreno et al. PEDIATRIC BLOOD & CANCER
- Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis
- (2017) Yongxing Gong et al. NEOPLASIA
- A Recurrent Mutation in PARK2 Is Associated with Familial Lung Cancer
- (2015) Donghai Xiong et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma
- (2015) D.-C. Lin et al. CANCER RESEARCH
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
- (2015) Branden S Moriarity et al. NATURE GENETICS
- Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma
- (2015) JUN YAN et al. Molecular Medicine Reports
- Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma
- (2014) Kjetil Berner et al. ACTA ONCOLOGICA
- Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene
- (2014) Valentina La Cognata et al. CURRENT GENOMICS
- PARK2 orchestrates cyclins to avoid cancer
- (2014) Jiri Bartek et al. NATURE GENETICS
- Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
- (2014) Yongxing Gong et al. NATURE GENETICS
- Np63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis
- (2013) H. K. Bid et al. CANCER RESEARCH
- Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation
- (2013) Xiaodong Sun et al. CELL CYCLE
- An emerging role of PARK2 in cancer
- (2013) Liang Xu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cancer Incidence and Survival Among Children and Adolescents in Israel During the Years 1998 to 2007
- (2013) Ron Rabinowicz et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
- (2013) Gemma Gatta et al. LANCET ONCOLOGY
- Genome-wide association study identifies two susceptibility loci for osteosarcoma
- (2013) Sharon A Savage et al. NATURE GENETICS
- Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
- (2012) C. W. S. Yeo et al. CANCER RESEARCH
- PARK2andPACRGare commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome
- (2012) Marieta I. Toma et al. GENES CHROMOSOMES & CANCER
- Somatic Mutation of PARK2 Tumor Suppressor Gene is not Common in Common Solid Cancers
- (2012) Eun Mi Je et al. PATHOLOGY & ONCOLOGY RESEARCH
- Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane
- (2011) Saori R. Yoshii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer
- (2011) Mei Zhao et al. LUNG CANCER
- Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
- (2011) C. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Genomic Instabilities Underlying Two Common Fragile-Site-Associated Loci, PARK2 and DMD, in Germ Cell and Cancer Cell Lines
- (2010) Jun Mitsui et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells
- (2010) Shiam-Peng Tay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
- (2010) G. Poulogiannis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of STAT3 activation and expression in canine and human osteosarcoma
- (2009) Stacey L Fossey et al. BMC CANCER
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release
- (2009) A. K. Berger et al. HUMAN MOLECULAR GENETICS
- Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism
- (2009) Hongxia Wang et al. JOURNAL OF PATHOLOGY
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Parkin as a tumor suppressor gene for hepatocellular carcinoma
- (2008) M Fujiwara et al. ONCOGENE
- The PTEN–PI3K pathway: of feedbacks and cross-talks
- (2008) A Carracedo et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started